BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2000610)

  • 41. Eosinophilia after allogeneic bone marrow transplantation using the busulfan and cyclophosphamide preparative regimen.
    Kalaycioglu ME; Bolwell BJ
    Bone Marrow Transplant; 1994 Jul; 14(1):113-5. PubMed ID: 7951097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Autologous bone marrow transplantation in malignant hematologic diseases].
    Johnsen HE; Birgens H; Hansen NE
    Ugeskr Laeger; 1991 Jun; 153(25):1790-3. PubMed ID: 1853458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Allogeneic bone marrow transplantation in the treatment of leukemia: analysis of 10 cases].
    Cao LX; Zeng TQ; Chen H
    Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):415-7, 456. PubMed ID: 1684316
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic myeloid leukemia treated by allogeneic bone marrow transplantation.
    Szer J; Sheridan WP
    Transplant Proc; 1992 Feb; 24(1):181-2. PubMed ID: 1539235
    [No Abstract]   [Full Text] [Related]  

  • 45. Successful pregnancy after total body irradiation and bone marrow transplantation for acute leukaemia.
    Giri N; Vowels MR; Barr AL; Mameghan H
    Bone Marrow Transplant; 1992 Jul; 10(1):93-5. PubMed ID: 1515886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia.
    Barrett AJ
    Leukemia; 1992; 6 Suppl 2():139-43. PubMed ID: 1578917
    [No Abstract]   [Full Text] [Related]  

  • 47. Allogeneic marrow transplantation in the treatment of infants with cancer.
    Johnson FL; Rubin CM
    Br J Cancer Suppl; 1992 Aug; 18():S76-9. PubMed ID: 1503931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fractionated total body irradiation and allogeneic bone marrow transplantation for standard risk leukemia.
    Altschuler C; Resbeut M; Maraninchi D; Guillet JP; Blaise D; Stoppa AM; Carcassonne Y
    Radiother Oncol; 1989 Dec; 16(4):289-95. PubMed ID: 2694233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of various conditioning regimens on the outcome of bone marrow transplantation for leukemia.
    Devergie A; Socie G; Esperou-Bourdeau H; Ribaud P; Traineau R; Gluckman E
    Nouv Rev Fr Hematol (1978); 1991; 33(6):437-9. PubMed ID: 1818295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation.
    Dimopoulos MA; Yau JC; Huan SD; Jagannath S; Spitzer G; Spinolo JA; Zagars GK; LeMaistre CF; Dicke KA; Zander AR
    Am J Hematol; 1994 Jun; 46(2):82-6. PubMed ID: 8172200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acalculous cholecystitis after bone marrow transplantation in adults with acute leukaemia. Case report.
    Pitkäranta P; Haapiainen R; Taavitsainen M; Elonen E
    Eur J Surg; 1991 May; 157(5):361-4. PubMed ID: 1678652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current status of allogeneic bone marrow transplantation.
    Sobocinski KA; Horowitz MM; Rimm AA; Bortin MM
    Biomed Pharmacother; 1992; 46(2-3):57-69. PubMed ID: 1421039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transplants in ALL.
    Barrett AJ; Horowitz MM
    Bone Marrow Transplant; 1992; 10 Suppl 1():30-6. PubMed ID: 1521088
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hematuric cystitis after bone marrow allograft: a case].
    Bontemps I; Frappaz D; Levignes F; Freycon F
    Pediatrie; 1992; 47(7-8):525-9. PubMed ID: 1336164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allogeneic and autologous bone marrow transplantation for high risk acute lymphoblastic leukemia.
    Kersey J; Weisdorf D; Uckun F; Vallera D; Jansen B; Nesbit M; Haake R; Ramsay N
    Leukemia; 1992; 6 Suppl 2():191-2. PubMed ID: 1578930
    [No Abstract]   [Full Text] [Related]  

  • 56. Risk factors for early mortality in allogeneic bone marrow transplantation. A multivariate analysis on 174 leukaemia patients.
    Valls A; Algara M; Marrugat J; Carreras E; Sierra J; Grañena A
    Eur J Cancer; 1993; 29A(11):1523-8. PubMed ID: 8217355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allogeneic bone marrow transplantation for hematological malignancies following etoposide, cyclophosphamide, and fractionated total body irradiation.
    Yau JC; LeMaistre CF; Andersson BS; Huan SD; Wallerstein RO; Woo SY; Spitzer G; Spinolo JA; Spencer V; Brunner LJ
    Am J Hematol; 1992 Sep; 41(1):40-4. PubMed ID: 1503097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subclinical pulmonary function defects following autologous and allogeneic bone marrow transplantation: relationship to total body irradiation and graft-versus-host disease.
    Tait RC; Burnett AK; Robertson AG; McNee S; Riyami BM; Carter R; Stevenson RD
    Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1219-27. PubMed ID: 2045296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic myelocytic leukemia: development of conditioning regimens for marrow transplantation.
    Storb R
    Leukemia; 1993 Aug; 7 Suppl 2():S135-7. PubMed ID: 8361218
    [No Abstract]   [Full Text] [Related]  

  • 60. Bone marrow transplantation in childhood leukemia using reverse isolation techniques.
    Ogden AK; Steuber CP; Mahoney DH; Fernbach DJ
    Med Pediatr Oncol; 1990; 18(1):1-5. PubMed ID: 2403630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.